You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: April 14, 2021

DrugPatentWatch Database Preview

EXSERVAN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

DrugPatentWatch® Litigation and Generic Entry Outlook for Exservan

A generic version of EXSERVAN was approved as riluzole by IMPAX LABS on January 29th, 2003.

  Start Trial

Summary for EXSERVAN
International Patents:161
US Patents:2
Suppliers / Packagers: 1
Formulation / Manufacturing:see details
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for EXSERVAN
What excipients (inactive ingredients) are in EXSERVAN?EXSERVAN excipients list
DailyMed Link:EXSERVAN at DailyMed
Drug patent expirations by year for EXSERVAN
Pharmacology for EXSERVAN
Drug ClassBenzothiazole

US Patents and Regulatory Information for EXSERVAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aquestive Therap EXSERVAN riluzole FILM;ORAL 212640-001 Nov 22, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Aquestive Therap EXSERVAN riluzole FILM;ORAL 212640-001 Nov 22, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.